The FY2025 (Dec) proxy of Cogent Biosciences names 20 peer companies for pay. Among Cogent Biosciences and these peers, CEO pay was the highest of 7 and total shareholder return was the highest of 7.
1st highest of 7in Cogent Biosciences and its pay peers, FY2025 (Dec) by CEO pay:
$4.6M$27.8M
1st highest of 7in Cogent Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:
$20$414
Pay peer group, FY2025 (Dec) proxy
| Arcus Biosciences | ||
| Immunome | ||
| Anaptysbio | ||
| Celldex Therapeutics | ||
| Kura Oncology | ||
| Relay Therapeutics | ||
| Allogene Therapeutics, Inc. | Not disclosed | Not disclosed |
| Arvinas, Inc. | Not disclosed | Not disclosed |
| Bicycle Therapeutics plc | Not disclosed | Not disclosed |
| Blueprint Medicines Corporation | Not disclosed | Not disclosed |
| Day One Biopharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Erasca, Inc. | Not disclosed | Not disclosed |
| IGM Biosciences, Inc. | Not disclosed | Not disclosed |
| Iovance Biotherapeutics | Not disclosed | Not disclosed |
| Kiniksa Pharmaceuticals, Ltd. | Not disclosed | Not disclosed |
| Nuvalent, Inc. | Not disclosed | Not disclosed |
| SpringWorks Therapeutics, Inc. | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Tyra Biosciences, Inc. | Not disclosed | Not disclosed |
| Xencor | Not disclosed | Not disclosed |
20 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.